Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

被引:7
|
作者
Kim, Mihui [1 ]
Yang, Yong Sook [1 ]
Ko, Young-Guk [2 ]
Choi, Mona [3 ]
机构
[1] Yonsei Univ, Coll Nursing, Brain Korea 21 4 Project, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
diabetes mellitus; exercise; major adverse cardiovascular event; major adverse limb event; peripheral artery disease; CHRONIC KIDNEY-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; ASSOCIATION; EPIDEMIOLOGY; MECHANISMS; EXERCISE; SYSTEM;
D O I
10.3390/jcm11092547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Plasma Gut Microbe-Derived Metabolites Associated with Peripheral Artery Disease and Major Adverse Cardiac Events
    Ho, Karen J.
    Ramirez, Joel L.
    Kulkarni, Rohan
    Harris, Katharine G.
    Helenowski, Irene
    Xiong, Liqun
    Ozaki, C. Keith
    Grenon, S. Marlene
    MICROORGANISMS, 2022, 10 (10)
  • [42] Characteristics and outcomes of patients with peripheral artery disease undergoing endovascular revascularization: A community hospital perspective
    Michael Gharacholou, S.
    Li, Zhuo
    Uy, Jonathan J.
    Eckstein, Lee H.
    Flock, Carolyn R.
    Senger, Joshua L.
    Gutierrez, Jorge F. Trejo
    Chapman, Scott C.
    VASCULAR, 2021, 29 (03) : 372 - 379
  • [43] Chronic Kidney Disease Predicts Adverse Major Cardiovascular Events and Adverse Limb Events in Patients With Diabetes and Peripheral Arterial Disease
    Rerkasem, Amaraporn
    Mangklabruks, Ampica
    Buranapin, Supawan
    Sony, Kiran
    Inpankaew, Nimit
    Rerkasem, Rath
    Pongtam, Sasinat
    Phirom, Kochaphan
    Rerkasem, Kitttipan
    INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS, 2024, 23 (01) : 19 - 26
  • [44] Association of Serum Lipoprotein (a) With the Requirement for a Peripheral Artery Operation and the Incidence of Major Adverse Cardiovascular Events in People With Peripheral Artery Disease
    Golledge, Jonathan
    Rowbotham, Sophie
    Velu, Ramesh
    Quigley, Frank
    Jenkins, Jason
    Bourke, Michael
    Bourke, Bernie
    Thanigaimani, Shivshankar
    Chan, Dick C.
    Watts, Gerald F.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (06):
  • [45] Identification and Evaluation of Angiogenesis-Related Proteins That Predict Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease
    Li, Ben
    Shaikh, Farah
    Younes, Houssam
    Abuhalimeh, Batool
    Chin, Jason
    Rasheed, Khurram
    Zamzam, Abdelrahman
    Abdin, Rawand
    Qadura, Mohammad
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (12)
  • [46] Rivaroxaban to reduce the risk of major cardiovascular events in patients with chronic coronary artery disease or peripheral artery disease: a narrative review
    Abdul-Rahman, Toufik
    Roy, Poulami
    Herrera-Calderon, Ranferi Eduardo
    Mueller-Gomez, Jann Ludwig
    Lisbona-Buzali, Marcos
    Ulusan, Sebahat
    Awuah, Wireko Andrew
    Kuchma, Nataliia
    Mehta, Nikhil
    Agrawal, Ankit
    Altibi, Ahmed
    Gupta, Rahul
    EXPERT OPINION ON DRUG SAFETY, 2025, : 261 - 271
  • [47] Different Mid-Term Prognostic Predictors of Major Adverse Events in Diabetic and Nondiabetic Peripheral Artery Disease Presenting With Critical Limb Ischemia
    Liang, Kae-Woei
    Kuo, Hsun-Nan
    Lee, Wen-Lieng
    Liu, Tsun-Jui
    Lin, Wei-Wen
    Tsao, Chen-Rong
    Ting, Chih-Tai
    Wang, Kuo-Yang
    ANGIOLOGY, 2016, 67 (03) : 287 - 291
  • [48] Association of chronic kidney disease categories defined with different formulae with major adverse events in patients with peripheral vascular disease
    Golledge, Jonathan
    Ewels, Carla
    Muller, Reinhold
    Walker, Phillip J.
    ATHEROSCLEROSIS, 2014, 232 (02) : 289 - 297
  • [49] Major adverse cardiac events in elderly patients with coronary artery disease undergoing noncardiac surgery: A multicenter prospective study in China
    Xu, Li
    Yu, Chunhua
    Jiang, Jingmei
    Zheng, Hong
    Yao, Shanglong
    Pei, Ling
    Sun, Li
    Xue, Fang
    Huang, Yuguang
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2015, 61 (03) : 503 - 509
  • [50] Risk of major adverse cardiovascular events in patients with metabolic syndrome after revascularization: A meta-analysis of eighteen cohorts with 18457 patients
    Tie, Hong-Tao
    Shi, Rui
    Li, Zhen-Han
    Zhang, Min
    Zhang, Cheng
    Wu, Qing-Chen
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (10): : 1224 - 1234